BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11904335)

  • 1. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.
    Torbenson M; Lee JH; Choti M; Gage W; Abraham SC; Montgomery E; Boitnott J; Wu TT
    Mod Pathol; 2002 Mar; 15(3):189-96. PubMed ID: 11904335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
    Chen YW; Jeng YM; Yeh SH; Chen PJ
    Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas.
    Choi YW; Heath EI; Heitmiller R; Forastiere AA; Wu TT
    Mod Pathol; 2000 Oct; 13(10):1055-9. PubMed ID: 11048797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
    Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
    Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
    Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
    Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
    Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APC mutations are infrequent but present in human lung cancer.
    Ohgaki H; Kros JM; Okamoto Y; Gaspert A; Huang H; Kurrer MO
    Cancer Lett; 2004 Apr; 207(2):197-203. PubMed ID: 15072829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
    Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K
    J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.
    Fujimori M; Ikeda S; Shimizu Y; Okajima M; Asahara T
    Cancer Res; 2001 Sep; 61(18):6656-9. PubMed ID: 11559529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
    Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
    Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.
    Clements WM; Wang J; Sarnaik A; Kim OJ; MacDonald J; Fenoglio-Preiser C; Groden J; Lowy AM
    Cancer Res; 2002 Jun; 62(12):3503-6. PubMed ID: 12067995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
    Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
    J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
    Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J
    Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.
    Sawyer EJ; Hanby AM; Rowan AJ; Gillett CE; Thomas RE; Poulsom R; Lakhani SR; Ellis IO; Ellis P; Tomlinson IP
    J Pathol; 2002 Apr; 196(4):437-44. PubMed ID: 11920740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
    Kim Y; Sills RC; Houle CD
    Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenomas.
    Fu X; Li J; Li K; Tian X; Zhang Y
    Histopathology; 2009 Nov; 55(5):554-63. PubMed ID: 19912361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis.
    Hao X; Frayling IM; Willcocks TC; Han W; Tomlinson IP; Pignatelli MN; Pretlow TP; Talbot IC
    Virchows Arch; 2002 Apr; 440(4):362-6. PubMed ID: 11956815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.